NMLSF (Restart Life Sciences) Common Stock: $39.28 Mil (As of Mar. 2026)


What is Restart Life Sciences Common Stock?

Restart Life Sciences NMLSF -41.67% Common Stock is $39.28 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Restart Life Sciences's quarterly common stock increased from Sep. 2025 ($37.36 Mil) to Dec. 2025 ($38.70 Mil) and increased from Dec. 2025 ($38.70 Mil) to Mar. 2026 ($39.28 Mil).

Restart Life Sciences's annual common stock declined from Dec. 2023 ($37.41 Mil) to Dec. 2024 ($35.46 Mil) but then increased from Dec. 2024 ($35.46 Mil) to Dec. 2025 ($38.70 Mil).

Restart Life Sciences Common Stock Historical Data

* Premium members only.

The historical data trend for Restart Life Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Restart Life Sciences Common Stock Chart

Restart Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.79 36.85 37.41 35.46 38.70

Restart Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.82 37.75 37.36 38.70 39.28

Restart Life Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $39.28 Mil mean?
Restart Life Sciences (NMLSF) has a Common Stock of $39.28 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Restart Life Sciences and its competitors.
Is Restart Life Sciences' Common Stock too high?
Restart Life Sciences' current Common Stock is $39.28 Mil.
How does Restart Life Sciences' Common Stock compare to VRTX and REGN?
Restart Life Sciences' Common Stock of $39.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Restart Life Sciences and its competitors. Restart Life Sciences's current Common Stock is $39.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Restart Life Sciences stock overvalued right now?
Restart Life Sciences (NMLSF) has a current Common Stock of $39.28 Mil. The current Common Stock is $39.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Restart Life Sciences (NMLSF), the current Common Stock is $39.28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Restart Life Sciences Business Description

Other Exchanges HEAL:Canada
Address 700 - 838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian-based life sciences company dedicated to addressing health challenges with wellness solutions. Its brands include HolyCrap, BrainQ, Brain Balls.